Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 29, 2010

Premium

Arrowhead Research, the parent company of Calando Pharmaceuticals, said that it has appointed Andrew von Eschenbach to its scientific advisory board.

Von Eschenbach was previously commissioner of the US Food and Drug Administration. Before that, he was director of the National Cancer Institute. He currently serves as senior director for strategic initiatives at the Center for Health Transformation, a think tank founded by Newt Gingrich.